These effects, along with a prior report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 assistance the strategy of targeting ACKR3 as a novel approach to modulate the opioid process, which could open up new therapeutic avenues for opioid-connected disorders. Disclaimer: The above can be https://roselynek405evn1.creacionblog.com/profile